Oxford scientists are using the latest virtual reality technology to study how we perceive the world in 3D. The “immersive virtual reality” used by the Virtual Reality Research Group at Oxford University allows subjects to walk around or look up and down while what they see through a headset changes accordingly – they can explore the virtual environment by literally walking around. Meanwhile, the scientists monitor how they are perceiving the dimensions of their ‘Matrix’-style world.

The res

Car owners of the future could one day swap petrol for environmentally-friendly alternatives, thanks to a multi-million pound research project involving academics at The University of Nottingham.

Researchers from the University’s School of Chemistry and School of Mechanical, Materials, Manufacturing Engineering and Management are developing new materials for hydrogen storage and for use in fuel cells that can use hydrogen as a clean alternative to oil and natural gas.

If new ma

A research study at The University of Nottingham looking at how growth can contribute to spontaneous childhood cancer regression could lead to more effective ways of treating tumours.

The one-year project, led by Christopher Jones in the School of Nursing in collaboration with Dr Michael Symonds in the Division of Child Health and Dr David Walker at the University’s Children’s Brain Tumour Research Centre, will look at whether growth hormone plays a part in tumours spontaneously ge

Academics at The University of Nottingham are developing new nanotechnology that could be used to treat brain tumours more effectively by reducing the serious side-effects associated with anti-cancer drugs.

A team led by Dr Martin Garnett in the School of Pharmaceutical Sciences has been awarded a £206,000 grant from the Biotechnology and Biological Sciences Research Council to continue investigations on the preparation of nanoparticles for delivering drugs to brain tumours.

Anti-c

Authors of a study published on THE LANCET’S website today (www.thelancet.com) highlight how statins (cholesterol-lowering drugs) could offer protection against cardiovascular disease for people who have undergone kidney transplantation.

Kidney-transplant patients are at an increased risk of premature cardiovascular disease; many transplant recipients have pre-existing cardiovascular disease at the time of transplantation and immunosuppressive therapy may aggravate existing risk factors or p

Patients with cancer of the larynx are likely to retain their voice and avoid surgery if they are treated simultaneously with chemotherapy and radiotherapy, say investigators who have conducted a nationwide study.

The findings are so significant they should become the new standard of care for stage III and IV laryngeal cancer, says one of the study’s lead investigators, Moshe Maor, M.D., professor of radiation oncology at The University of Texas M. D. Anderson Cancer Center.